Jill Hutzelmann

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

David Michelson, Ellen Snyder, Erin M. Paradis et al. · The Lancet Neurology · 2014 · 503 citations

Sleep Medicine, Sleep, 1-Year Treatment +9

Orexin receptor antagonism for treatment of insomnia

W. Joseph Herring, Ellen Snyder, Kerry Budd et al. · Neurology · 2012 · 317 citations

Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials

W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May et al. · Biological Psychiatry · 2014 · 284 citations

Sleep Disorders, Sleep, Sleep Disorder +5

Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial

W. Joseph Herring, Paulette Ceesay, Ellen Snyder et al. · Alzheimer s & Dementia · 2020 · 174 citations · Full text

Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study

Jill Hutzelmann, Sally Owens, Arthur Shedden et al. · British Journal of Ophthalmology · 1998 · 102 citations · Full text